Furthermore, Wei et al. showed that digoxin inhibited non-small-cell lung cancer cell growth as it acts as a potent inhibitor of HIF-1α synthesis in A549 cells, causing downregulation of hypoxia-induced VEGF and NDRG1 overexpression (Wei et al., 2013). Here, HIF1A is linked to non-small cell lung carcinoma.